Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

News feed

DOM.RF forecasts dividends for 2025

12/12/25 DOMRF

Ozon bought 1 million shares as part of buyback

12/12/25 OZON

Shareholders of Diasoft approved dividends

12/12/25 DIAS

Europlan plans to double its profit

12/12/25 LEAS

Aeroflot passenger traffic in November increased by 2.8%

12/12/25 AFLT

Henderson opened the first salon in Tolyatti

12/12/25 HNFG

Yandex is developing an electric taxi vehicle under its own brand

12/12/25 YDEX

Shareholders of Polyus approved dividends for 9 months 2025

12/11/25 PLZL

Structure associated with Lenta received O'key hypermarkets

12/11/25 LENT

Sollers presented the seven-seat minibus Sollers SF1

12/11/25 SVAV